Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia

Alexander P. Reiner, Jaana Hartiala, Tanja Zeller, Joshua C. Bis, Josée Dupuis, Myriam Fornage, Jens Baumert, Marcus E. Kleber, Philipp S. Wild, Stephan Baldus, Suzette J. Bielinski, Joao Daniel T. Fontes, Thomas Illig, Brendan J. Keating, Leslie A. Lange, Francisco Ojeda, Martina Müller-Nurasyid, Thomas F. Munzel, Bruce M. Psaty, Kenneth RiceJerome I. Rotter, Renate B. Schnabel, W. H Wilson Tang, Barbara Thorand, Jeanette Erdmann, David R. Jacobs, James G. Wilson, Wolfgang Koenig, Russell P. Tracy, Stefan Blankenberg, Winfried März, Myron D. Gross, Emelia J. Benjamin, Stanley L. Hazen, Hooman Allayee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Increased systemic levels of myeloperoxidase (MPO) are associated with the risk of coronary artery disease (CAD). To identify the genetic factors that are associated with circulating MPO levels, we carried out a genome-wide association study (GWAS) and a gene-centric analysis in subjects of European ancestry and African Americans (AAs). A locus on chromosome 1q31.1 containing the complement factor H (CFH) gene was strongly associated with serum MPO levels in 9305 subjects of European ancestry (lead SNP rs800292; P = 4.89 × 10-41) and in 1690 AA subjects (rs505102; P = 1.05 × 10-8). Gene-centric analyses in 8335 subjects of European ancestry additionally identified two rare MPO coding sequence variants that were associated with serumMPOlevels (rs28730837, P = 5.21 × 10-12; rs35897051, P = 3.32 × 10-8).AGWAS for plasma MPO levels in 9260 Europeanancestry subjects identified a chromosome 17q22 regionnear MPO that was significantly associated (lead SNP rs6503905; P = 2.94 × 10-12), but the CFH locus did not exhibit evidence of association with plasma MPO levels. Functional analyses revealed that rs800292 was associated with levels of complement proteins in serum. Variants at chromosome 17q22 also had pleiotropic cis effects on gene expression. In a case- control analysis of ̃80 000 subjects from CARDIoGRAM, none of the identified single-nucleotide polymorphisms (SNPs) were associated with CAD. These results suggest that distinct genetic factors regulate serum and plasma MPO levels, which may have relevance for various acute and chronic inflammatory disorders. The clinical implications for CAD and a better understanding of the functional basis for the association of CFH and MPO variants with circulating MPO levels require further study.

Original languageEnglish (US)
Article numberddt189
Pages (from-to)3381-3393
Number of pages13
JournalHuman Molecular Genetics
Volume22
Issue number16
DOIs
StatePublished - Aug 2013
Externally publishedYes

Fingerprint

Peroxidase
Genome
Genes
Complement Factor H
Single Nucleotide Polymorphism
Coronary Artery Disease
Chromosomes
African Americans
Serum
Genome-Wide Association Study
Complement System Proteins
Gene Expression

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Reiner, A. P., Hartiala, J., Zeller, T., Bis, J. C., Dupuis, J., Fornage, M., ... Allayee, H. (2013). Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia. Human Molecular Genetics, 22(16), 3381-3393. [ddt189]. https://doi.org/10.1093/hmg/ddt189

Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia. / Reiner, Alexander P.; Hartiala, Jaana; Zeller, Tanja; Bis, Joshua C.; Dupuis, Josée; Fornage, Myriam; Baumert, Jens; Kleber, Marcus E.; Wild, Philipp S.; Baldus, Stephan; Bielinski, Suzette J.; Fontes, Joao Daniel T.; Illig, Thomas; Keating, Brendan J.; Lange, Leslie A.; Ojeda, Francisco; Müller-Nurasyid, Martina; Munzel, Thomas F.; Psaty, Bruce M.; Rice, Kenneth; Rotter, Jerome I.; Schnabel, Renate B.; Tang, W. H Wilson; Thorand, Barbara; Erdmann, Jeanette; Jacobs, David R.; Wilson, James G.; Koenig, Wolfgang; Tracy, Russell P.; Blankenberg, Stefan; März, Winfried; Gross, Myron D.; Benjamin, Emelia J.; Hazen, Stanley L.; Allayee, Hooman.

In: Human Molecular Genetics, Vol. 22, No. 16, ddt189, 08.2013, p. 3381-3393.

Research output: Contribution to journalArticle

Reiner, AP, Hartiala, J, Zeller, T, Bis, JC, Dupuis, J, Fornage, M, Baumert, J, Kleber, ME, Wild, PS, Baldus, S, Bielinski, SJ, Fontes, JDT, Illig, T, Keating, BJ, Lange, LA, Ojeda, F, Müller-Nurasyid, M, Munzel, TF, Psaty, BM, Rice, K, Rotter, JI, Schnabel, RB, Tang, WHW, Thorand, B, Erdmann, J, Jacobs, DR, Wilson, JG, Koenig, W, Tracy, RP, Blankenberg, S, März, W, Gross, MD, Benjamin, EJ, Hazen, SL & Allayee, H 2013, 'Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia', Human Molecular Genetics, vol. 22, no. 16, ddt189, pp. 3381-3393. https://doi.org/10.1093/hmg/ddt189
Reiner, Alexander P. ; Hartiala, Jaana ; Zeller, Tanja ; Bis, Joshua C. ; Dupuis, Josée ; Fornage, Myriam ; Baumert, Jens ; Kleber, Marcus E. ; Wild, Philipp S. ; Baldus, Stephan ; Bielinski, Suzette J. ; Fontes, Joao Daniel T. ; Illig, Thomas ; Keating, Brendan J. ; Lange, Leslie A. ; Ojeda, Francisco ; Müller-Nurasyid, Martina ; Munzel, Thomas F. ; Psaty, Bruce M. ; Rice, Kenneth ; Rotter, Jerome I. ; Schnabel, Renate B. ; Tang, W. H Wilson ; Thorand, Barbara ; Erdmann, Jeanette ; Jacobs, David R. ; Wilson, James G. ; Koenig, Wolfgang ; Tracy, Russell P. ; Blankenberg, Stefan ; März, Winfried ; Gross, Myron D. ; Benjamin, Emelia J. ; Hazen, Stanley L. ; Allayee, Hooman. / Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia. In: Human Molecular Genetics. 2013 ; Vol. 22, No. 16. pp. 3381-3393.
@article{fae8fa0134884cbfa50a2394ac0003cd,
title = "Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia",
abstract = "Increased systemic levels of myeloperoxidase (MPO) are associated with the risk of coronary artery disease (CAD). To identify the genetic factors that are associated with circulating MPO levels, we carried out a genome-wide association study (GWAS) and a gene-centric analysis in subjects of European ancestry and African Americans (AAs). A locus on chromosome 1q31.1 containing the complement factor H (CFH) gene was strongly associated with serum MPO levels in 9305 subjects of European ancestry (lead SNP rs800292; P = 4.89 × 10-41) and in 1690 AA subjects (rs505102; P = 1.05 × 10-8). Gene-centric analyses in 8335 subjects of European ancestry additionally identified two rare MPO coding sequence variants that were associated with serumMPOlevels (rs28730837, P = 5.21 × 10-12; rs35897051, P = 3.32 × 10-8).AGWAS for plasma MPO levels in 9260 Europeanancestry subjects identified a chromosome 17q22 regionnear MPO that was significantly associated (lead SNP rs6503905; P = 2.94 × 10-12), but the CFH locus did not exhibit evidence of association with plasma MPO levels. Functional analyses revealed that rs800292 was associated with levels of complement proteins in serum. Variants at chromosome 17q22 also had pleiotropic cis effects on gene expression. In a case- control analysis of ̃80 000 subjects from CARDIoGRAM, none of the identified single-nucleotide polymorphisms (SNPs) were associated with CAD. These results suggest that distinct genetic factors regulate serum and plasma MPO levels, which may have relevance for various acute and chronic inflammatory disorders. The clinical implications for CAD and a better understanding of the functional basis for the association of CFH and MPO variants with circulating MPO levels require further study.",
author = "Reiner, {Alexander P.} and Jaana Hartiala and Tanja Zeller and Bis, {Joshua C.} and Jos{\'e}e Dupuis and Myriam Fornage and Jens Baumert and Kleber, {Marcus E.} and Wild, {Philipp S.} and Stephan Baldus and Bielinski, {Suzette J.} and Fontes, {Joao Daniel T.} and Thomas Illig and Keating, {Brendan J.} and Lange, {Leslie A.} and Francisco Ojeda and Martina M{\"u}ller-Nurasyid and Munzel, {Thomas F.} and Psaty, {Bruce M.} and Kenneth Rice and Rotter, {Jerome I.} and Schnabel, {Renate B.} and Tang, {W. H Wilson} and Barbara Thorand and Jeanette Erdmann and Jacobs, {David R.} and Wilson, {James G.} and Wolfgang Koenig and Tracy, {Russell P.} and Stefan Blankenberg and Winfried M{\"a}rz and Gross, {Myron D.} and Benjamin, {Emelia J.} and Hazen, {Stanley L.} and Hooman Allayee",
year = "2013",
month = "8",
doi = "10.1093/hmg/ddt189",
language = "English (US)",
volume = "22",
pages = "3381--3393",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "16",

}

TY - JOUR

T1 - Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia

AU - Reiner, Alexander P.

AU - Hartiala, Jaana

AU - Zeller, Tanja

AU - Bis, Joshua C.

AU - Dupuis, Josée

AU - Fornage, Myriam

AU - Baumert, Jens

AU - Kleber, Marcus E.

AU - Wild, Philipp S.

AU - Baldus, Stephan

AU - Bielinski, Suzette J.

AU - Fontes, Joao Daniel T.

AU - Illig, Thomas

AU - Keating, Brendan J.

AU - Lange, Leslie A.

AU - Ojeda, Francisco

AU - Müller-Nurasyid, Martina

AU - Munzel, Thomas F.

AU - Psaty, Bruce M.

AU - Rice, Kenneth

AU - Rotter, Jerome I.

AU - Schnabel, Renate B.

AU - Tang, W. H Wilson

AU - Thorand, Barbara

AU - Erdmann, Jeanette

AU - Jacobs, David R.

AU - Wilson, James G.

AU - Koenig, Wolfgang

AU - Tracy, Russell P.

AU - Blankenberg, Stefan

AU - März, Winfried

AU - Gross, Myron D.

AU - Benjamin, Emelia J.

AU - Hazen, Stanley L.

AU - Allayee, Hooman

PY - 2013/8

Y1 - 2013/8

N2 - Increased systemic levels of myeloperoxidase (MPO) are associated with the risk of coronary artery disease (CAD). To identify the genetic factors that are associated with circulating MPO levels, we carried out a genome-wide association study (GWAS) and a gene-centric analysis in subjects of European ancestry and African Americans (AAs). A locus on chromosome 1q31.1 containing the complement factor H (CFH) gene was strongly associated with serum MPO levels in 9305 subjects of European ancestry (lead SNP rs800292; P = 4.89 × 10-41) and in 1690 AA subjects (rs505102; P = 1.05 × 10-8). Gene-centric analyses in 8335 subjects of European ancestry additionally identified two rare MPO coding sequence variants that were associated with serumMPOlevels (rs28730837, P = 5.21 × 10-12; rs35897051, P = 3.32 × 10-8).AGWAS for plasma MPO levels in 9260 Europeanancestry subjects identified a chromosome 17q22 regionnear MPO that was significantly associated (lead SNP rs6503905; P = 2.94 × 10-12), but the CFH locus did not exhibit evidence of association with plasma MPO levels. Functional analyses revealed that rs800292 was associated with levels of complement proteins in serum. Variants at chromosome 17q22 also had pleiotropic cis effects on gene expression. In a case- control analysis of ̃80 000 subjects from CARDIoGRAM, none of the identified single-nucleotide polymorphisms (SNPs) were associated with CAD. These results suggest that distinct genetic factors regulate serum and plasma MPO levels, which may have relevance for various acute and chronic inflammatory disorders. The clinical implications for CAD and a better understanding of the functional basis for the association of CFH and MPO variants with circulating MPO levels require further study.

AB - Increased systemic levels of myeloperoxidase (MPO) are associated with the risk of coronary artery disease (CAD). To identify the genetic factors that are associated with circulating MPO levels, we carried out a genome-wide association study (GWAS) and a gene-centric analysis in subjects of European ancestry and African Americans (AAs). A locus on chromosome 1q31.1 containing the complement factor H (CFH) gene was strongly associated with serum MPO levels in 9305 subjects of European ancestry (lead SNP rs800292; P = 4.89 × 10-41) and in 1690 AA subjects (rs505102; P = 1.05 × 10-8). Gene-centric analyses in 8335 subjects of European ancestry additionally identified two rare MPO coding sequence variants that were associated with serumMPOlevels (rs28730837, P = 5.21 × 10-12; rs35897051, P = 3.32 × 10-8).AGWAS for plasma MPO levels in 9260 Europeanancestry subjects identified a chromosome 17q22 regionnear MPO that was significantly associated (lead SNP rs6503905; P = 2.94 × 10-12), but the CFH locus did not exhibit evidence of association with plasma MPO levels. Functional analyses revealed that rs800292 was associated with levels of complement proteins in serum. Variants at chromosome 17q22 also had pleiotropic cis effects on gene expression. In a case- control analysis of ̃80 000 subjects from CARDIoGRAM, none of the identified single-nucleotide polymorphisms (SNPs) were associated with CAD. These results suggest that distinct genetic factors regulate serum and plasma MPO levels, which may have relevance for various acute and chronic inflammatory disorders. The clinical implications for CAD and a better understanding of the functional basis for the association of CFH and MPO variants with circulating MPO levels require further study.

UR - http://www.scopus.com/inward/record.url?scp=84881241528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881241528&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddt189

DO - 10.1093/hmg/ddt189

M3 - Article

C2 - 23620142

AN - SCOPUS:84881241528

VL - 22

SP - 3381

EP - 3393

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 16

M1 - ddt189

ER -